Characteristics of psychiatric patients with hypokalemia after yokukansan administration: A retrospective study

Characteristics of psychiatric patients with hypokalemia after yokukansan administration: A retrospective study

Abstract Aim Yokukansan is a Japanese herbal medicine used in psychiatry to treat behavioral and psychological symptoms of dementia and other psychiatric symptoms. However, the glycyrrhizic acid included in this medicine can cause pseudoaldosteronism and hypokalemia. We aimed to identify the risk fa...

Full description

Bibliographic Details
Main Authors:	Kazuya Yasuda, Ryuichiro Takeda, Ryuji Ikeda, Yasushi Ishida
Format:	Article
Language:	English
Published:	Wiley 2023-03-01
Series:	PCN Reports
Subjects:	dementia hypokalemia psychiatric disorders risk factors yokukansan
Online Access:	https://doi.org/10.1002/pcn5.76

Similar Items

Cellular Pharmacological Effects of the Traditional Japanese Kampo Medicine Yokukansan on Brain Cells
by: Kazushige Mizoguchi, et al.
Published: (2017-09-01)

Yokukansan for perioperative psychiatric symptoms in cancer patients undergoing high invasive surgery. J-SUPPORT 1605 (ProD Study): study protocol for a randomized controlled trial
by: Saho Wada, et al.
Published: (2019-02-01)

Inhibitory effect of yokukansan on the decrease in the hippocampal excitatory amino acid transporter EAAT2 in stress-maladaptive mice
by: Hiroko Miyagishi, et al.
Published: (2017-10-01)

The Serotonin-Mediated Anti-Allodynic Effect of Yokukansan on Paclitaxel-Induced Neuropathic Pain
by: Hiroshi Yokomi, et al.
Published: (2024-02-01)

Basic Study of Drug-Drug Interaction between Memantine and the Traditional Japanese Kampo Medicine Yokukansan
by: Takashi Matsumoto, et al.
Published: (2018-12-01)

Kampo Formulae for the Treatment of Neuropathic Pain ∼ Especially the Mechanism of Action of Yokukansan ∼
by: Masataka Sunagawa, et al.
Published: (2021-12-01)

A multicenter, double‐blind, randomized, controlled study of patients with treatment‐resistant schizophrenia treated with yokukansan for 12 weeks
by: Jun Horiguchi, et al.
Published: (2023-12-01)

Yokukansan, a Kampo medicine, prevents the development of morphine tolerance through the inhibition of spinal glial cell activation in rats
by: Mariko Takemoto, et al.
Published: (2016-03-01)

Yokukansan (TJ-54) for treatment of pervasive developmental disorder not otherwise specified and Asperger’s disorder: a 12-week prospective, open-label study
by: Miyaoka Tsuyoshi, et al.
Published: (2012-11-01)

Recommendations for the management of hypokalemia in patients with cancer
by: Sandra Espinoza-Muñoz, et al.
Published: (2023-06-01)

Yokukansan and Yokukansankachimpihange Ameliorate Aggressive Behaviors in Rats with Cholinergic Degeneration in the Nucleus Basalis of Meynert
by: Masahiro Tabuchi, et al.
Published: (2017-04-01)

Inhibitory effect of the Kampo medicinal formula Yokukansan on acute stress-induced defecation in rats
by: Kanada Y, et al.
Published: (2018-04-01)

Yokukansan Inhibits the Development of Morphine Tolerance by Regulating Presynaptic Proteins in DRG Neurons
by: Yusuke Ohashi, et al.
Published: (2022-05-01)

Yokukansan, a Kampo medicine, enhances the level of neuronal lineage markers in differentiated P19 embryonic carcinoma cells
by: Makoto Fukui, et al.
Published: (2019-10-01)

The 2018 Japan Floods Increased the Frequency of Yokukansan Prescriptions Among Elderly: A Retrospective Cohort Study
by: Ryoko Ishida, et al.
Published: (2022-01-01)

Hypokalemia after rituximab administration in nephrotic syndrome: two case reports
by: Yiyun Song, et al.
Published: (2023-07-01)

The Japanese Herbal Medicine Yokukansan Exerted Antioxidant and Analgesic Effects in an Experimental Rat Model of Hunner-Type Interstitial Cystitis
by: Tatsuki Inoue, et al.
Published: (2022-06-01)

Traditional Japanese Herbal Medicine Yokukansan Targets Distinct but Overlapping Mechanisms in Aged Mice and in the 5xFAD Mouse Model of Alzheimer’s Disease
by: Rahul Kaushik, et al.
Published: (2018-12-01)

Incidence and Determinants of Piperacillin/Tazobactam-Associated Hypokalemia: A Retrospective Study
by: Heenam Seo, et al.
Published: (2022-08-01)

Therapeutic potential of clinically proven natural products in the management of dementia
by: Farzana Ansari, et al.
Published: (2024-03-01)

Impact of plasma potassium normalization on short-term mortality in patients with hypertension and hypokalemia or low normal potassium
by: Maria Lukács Krogager, et al.
Published: (2020-08-01)

A HYPOKALEMIA CASE RES?STANT TO TREATMENT ASSOCIATED WITH LEFLUNOMIDE
by: GÜLALİ AKTAŞ, et al.
Published: (2014-08-01)

Central pontinemyelinosis, hyperparathyroidism, hypokalemia
by: Shyam Kishore, et al.
Published: (2013-01-01)

Treatment strategies of hypokalemia in heart failure
by: Kavya Surendran, et al.
Published: (2022-01-01)

Hypokalemia Duration in the First Year Associated with Subsequent Peritoneal Dialysis-Associated Peritonitis: A Multicenter Retrospective Cohort Study
by: Zhihao Huo, et al.
Published: (2022-12-01)

Hypokalemia during the early phase of refeeding in patients with cancer
by: Simona Grasso, et al.
Published: (2013-11-01)

Pantoprazole induces bradyarrhythmia in mice with hypokalemia
by: LI Shuai, ZHU Wen-gen, YAN Xia, LAI Wei, YU Jian-hua, WAN Rong, HONG Kui
Published: (2020-01-01)

A Case of Hypokalemia with Synthetic Cannabinoid Use
by: Bengur Taskiran, et al.
Published: (2014-12-01)

Association between preoperative hypokalemia and postoperative complications in elderly patients: a retrospective study
by: Tiantian Chu, et al.
Published: (2022-09-01)

Young Female, Fatigue, Hypokalemia, Hyperglycemia
by: CHEN Rong, et al.
Published: (2024-03-01)

Hypokalemia : what correlation with psychotic relapse ?
by: B. Abassi, et al.
Published: (2022-06-01)

Addison’s disease associated with hypokalemia: a case report
by: M. Abdalla, et al.
Published: (2021-03-01)

Severe Hypokalemia as a Rare Presentation of Disseminated Tuberculosis
by: Mohammed O. Khalil, et al.
Published: (2021-11-01)

Oral acyclovir induced hypokalemia and acute tubular necrosis a case report
by: Jonathan S. Chávez-Iñiguez, et al.
Published: (2018-11-01)

Hypocalcemia and hypokalemia due to hyperventilation syndrome in spinal anesthesia -A case report-
by: Hyun Soo Moon, et al.
Published: (2011-12-01)

Hypokalemia in Diabetes Mellitus Setting
by: Lucas Coregliano-Ring, et al.
Published: (2022-03-01)

Refractory hypokalemia while weaning off bypass
by: Rashmi Soori, et al.
Published: (2018-01-01)

Association of Hyperkalemia and Hypokalemia with Patient Characteristics and Clinical Outcomes in Japanese Hemodialysis (HD) Patients
by: Masao Iwagami, et al.
Published: (2023-03-01)

Cicletanine-induced hyponatremia and hypokalemia in kidney transplant patients
by: Eun Young Choi, et al.
Published: (2016-09-01)

Ultrasound of the diaphragm in severe hypokalemia induced diaphragmatic dysfunction
by: Gentle Sunder Shrestha, et al.
Published: (2017-01-01)